New Delhi [India], November 19 (ANI): Major drug marker Serum of Institute of India (SII) on Thursday said that the coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years
New Delhi [India], November 19 (ANI): In a major development, UK's Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial.
Rohtak (Haryana) [India], November 19 (ANI): Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers by Thursday for the third-phase trial of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, that will begin from F
Washington [US], November 18 (ANI): American drug giant Pfizer on Wednesday said that final results from the late-stage trial of its coronavirus vaccine was found to be 95 per cent effective and had no serious side effects on older people.
Geneva [Switzerland], November 17 (ANI/Sputnik): The World Health Organisation (WHO) is concerned about surging COVID-19 cases in various countries, especially in Europe and the Americas, despite encouraging news about coronavirus vaccines, Director General Tedros Adhanom Ghebreyesus said on
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.
Geneva [Switzerland], November 12 (ANI/Sputnik): The World Health Organization (WHO) may add Russian coronavirus vaccine Sputnik V to the list of recommended vaccines for emergency use if the candidate meets necessary criteria, it has told Sputnik in a statement.
Ankara [Turkey], November 12 (ANI): Brazil's health regulator Anvisa on Wednesday (local time) announced the resumption of clinical trials of China's Sinovac COVID-19 vaccine.
Bern [Switzerland], November 12 (ANI/Sputnik): Switzerland has allotted additional 100 million Swiss francs (USD 109 million) for its fund earmarked to be spent on the purchase of coronavirus vaccines, the government said in a press release on Wednesday.
New Delhi [India], November 10 (ANI): A day after Pfizer Inc and BioNTech SE announced around 90 per cent efficacy of their COVID-19 vaccine in their ongoing phase three trial, the central government on Tuesday said that it is in dialogue with both the domestic and international vaccine manu
Washington [US], November 9 (ANI): The coronavirus vaccine developed by drug giant American Pfizer and German biotechnology firm BioNTech was more than 90 per cent effective at protecting people from infection as compared to placebo saline shot, according to an analysis.
Lusaka [Zambia], November 9 (ANI/Sputnik): Zambia is eager to get Russia's Sputnik V coronavirus vaccine as soon as it hits the market, the African nation's ambassador told Sputnik, adding that health ministers of the two countries were already in talks on the matter.